Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge

NCT07059767 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma (Diagnosis)

Interventions

DRUG: ETH47
DRUG: Placebo

Sponsor

Ethris GmbH

Collaborators

[object Object]